昆虫学报 ›› 2025, Vol. 68 ›› Issue (4): 499-508.doi: 10.16380/j.kcxb.2025.04.011

• 研究论文 • 上一篇    下一篇

韭菜迟眼蕈蚊的抗药性监测及对灭蝇胺的抗性风险和亚致死效应分析

刘佳乐1,2, 苏少聪1,2, 王洪涛3, 刘保友3, 柴宏飞4, 高聪芬1,2, 吴顺凡1,2,*   

  1. (1. 南京农业大学三亚研究院, 三亚 572000; 2. 南京农业大学植物保护学院, 南京 210095;3.山东省烟台市农业科学研究院, 烟台 265500; 4. 濮阳市植物保护检疫站, 濮阳 457000)
  • 出版日期:2025-04-20 发布日期:2025-05-22

Monitoring of insecticide resistance in Bradysia odoriphaga (Diptera: Sciaridae), and analysis of resistance risk and sublethal effect of cyromazine

LIU Jia-Le1,2, SU Shao-Cong1,2, WANG Hong-Tao3, LIU Bao-You3, CHAI Hong-Fei4, GAO Cong-Fen1,2, WU Shun-Fan1,2,*   

  1.  (1. Sanya Institute of Nanjing Agricultural University, Sanya 572000, China; 2. College of Plant Protection, Nanjing Agricultural University, Nanjing 210095, China; 3. Yantai Academy of Agricultural Sciences in Shandong Province, Yantai 265500, China; 4. Puyang City Plant Protection and Quarantine Station, Puyang 457000, China)
  • Online:2025-04-20 Published:2025-05-22

摘要: 【目的】明确韭菜迟眼蕈蚊Bradysia odoriphaga对10种杀虫剂的抗性现状及对灭蝇胺的抗性风险和灭蝇胺对韭菜迟眼蕈蚊的亚致死效应。【方法】采用胃毒触杀联合毒力法测定了5类(新烟碱类、拟除虫菊酯类、吡咯类、昆虫生长调节剂类和有机磷类)共10种杀虫剂对河南省濮阳市、安徽省亳州市、河北省唐山市及山东省济宁市4个地区韭菜迟眼蕈蚊2龄幼虫的毒力,用亚致死浓度(LC15和LC30)灭蝇胺处理韭菜迟眼蕈蚊观察对其幼虫历期、化蛹率、羽化率及单雌产卵量等指标的影响,评估了韭菜迟眼蕈蚊对灭蝇胺的抗性风险,并通过Tabashnik域性状分析法计算抗性现实遗传力(realized heritability, h2)和基于选择数据预测不同选择压力下的抗性发展速率。【结果】监测数据表明,韭菜迟眼蕈蚊田间种群对灭蝇胺、氟啶脲、氟铃脲和吡丙醚处于敏感至低水平抗性,对辛硫磷产生低至中等水平抗性,对高效氯氰菊酯处于低水平抗性,对吡虫啉、噻虫嗪和噻虫胺处于敏感或低至中等水平抗性。当抗性现实遗传力(h2)为0.073,在不同的选择压力下(死亡率分别为50%, 60%, 70%, 80%和90%),韭菜迟眼蕈蚊对灭蝇胺的抗性上升至10倍分别需要25.2, 20.7, 17.2, 14.4和11.4代;采用LC15和LC30浓度灭蝇胺处理韭菜迟眼蕈蚊2龄幼虫后, F0和F1代的羽化率和单雌产卵量显著降低。【结论】韭菜迟眼蕈蚊对灭蝇胺具有较低的抗性风险,亚致死浓度灭蝇胺显著抑制韭菜迟眼蕈蚊的化蛹率、羽化率及单雌产卵量。

关键词: 韭菜迟眼蕈蚊, 抗药性监测, 灭蝇胺, 抗性风险, 适合度代价

Abstract: 【Aim】To ascertain the resistance status of Bradysia odoriphaga to ten insecticides, the potential risk of resistance of B. odoriphaga to cyromazine and the sublethal effects of cyromazine on B. odoriphaga. 【Methods】We determined the toxicity of 10 insecticides of 5 categories (neonicotinoids, pyrethroids, pyrroles, insectgrowthregulatorsandorganophosphates) to the 2nd instar larvae of B. odoriphaga from four regions including Puyang City in Henan Province, Bozhou City in Anhui Province, Tangshan City in Hebei Province, and Jining City in Shandong Province with the stomach-contact combination toxicity method. We observed the effects of sublethal concentrations (LC15 and LC30) of cyromazine on the larval duration, pupation rate, emergence rate and number of eggs laid per female of B. odoriphaga, and assessed the risk of resistance to cyromazine. We calculated the realized heritability (h2) of resistance of B. odoriphaga using Tabashnik’s method for threshold trait analysis and predicted the resistance development rates under different selection pressures based on the data of selection. 【Results】 Monitoring data demonstrated that the field populations of B. odoriphaga were susceptible or exhibited low-level resistance to cyromazine, hexaflumuron, chlorfluazuron and pyriproxyfen, and showed low to moderate levels of resistance to phoxim. All the monitored populations of B. odoriphaga showed low-level resistance to beta-cypermethrin. All field populations of B. odoriphaga were susceptible or developed low to moderate levels of resistance to imidacloprid, clothianidin and thiamethoxam. It would take 25.2, 20.7, 17.2, 14.4 and 11.4 generations, respectively, to develop 10-fold resistance to cyromazine in B. odoriphaga, under different selection pressures (mortality rates of 50%, 60%, 70%, 80% and 90%, respectively) when the realized heritability (h2) of resistance was 0.073. The emergence rates and numbers of eggs laid per female of F0 and F1 generations of B. odoriphaga were significantly reduced after exposure of the 2nd instar larvae to LC15 and LC30 of cyromazine. 【Conclusion】B. odoriphaga has low resistance risk to cyromazine. Cyromazine treatment at sublethal concentrations exhibits significant inhibitory effects on the pupation rate, emergence rate, and number of eggs laid per female of B. odoriphaga.

Key words: Bradysia odoriphaga, insecticide resistance monitoring, cyromazine, resistance risk, fitness cost